Book contents
- Personal Genome Medicine
- Personal Genome Medicine
- Copyright page
- Dedication
- Contents
- Reader’s Note
- Acknowledgments
- Prologue
- 1 Medical Profession Sovereignty to Protect and Promote the Science and Evidence Base of US Medicine
- 2 US Integration of Government, Academia, and Industry
- 3 Direct-to-Consumer/DTC and Direct-to-Physician/DTP Biopharma Marketing in the US
- 4 The Evolution of Consumer Genetic Testing Services from Oncormed, Inc. to 23andMe Holding Co.
- 5 Vulnerability of the Science and Evidence Base of US Medicine
- 6 A Warning Label for Direct-to-Consumer/DTC Genetics and Genomics
- 7 Protecting and Promoting the Evidentiary-Science Base of Personal Genome Medicine/PGM
- Epilogue
- Index
Contents
Published online by Cambridge University Press: 30 August 2023
- Personal Genome Medicine
- Personal Genome Medicine
- Copyright page
- Dedication
- Contents
- Reader’s Note
- Acknowledgments
- Prologue
- 1 Medical Profession Sovereignty to Protect and Promote the Science and Evidence Base of US Medicine
- 2 US Integration of Government, Academia, and Industry
- 3 Direct-to-Consumer/DTC and Direct-to-Physician/DTP Biopharma Marketing in the US
- 4 The Evolution of Consumer Genetic Testing Services from Oncormed, Inc. to 23andMe Holding Co.
- 5 Vulnerability of the Science and Evidence Base of US Medicine
- 6 A Warning Label for Direct-to-Consumer/DTC Genetics and Genomics
- 7 Protecting and Promoting the Evidentiary-Science Base of Personal Genome Medicine/PGM
- Epilogue
- Index
Summary
- Type
- Chapter
- Information
- Personal Genome MedicineThe Legal and Regulatory Transformation of US Medicine, pp. vii - xPublisher: Cambridge University PressPrint publication year: 2023